Pharma PR Newswire

Pharma Focus Asia offers the most advanced strategies in Pharmaceutical Sector, the most significant developments in the industry and provides information on the latest research in Pharma Healthcare. The following Press Releases highlights the recent happenings in the Pharmaceutical Sector across the world.

PrimeTherapeutics Finds Use of Short Acting Opioids Decreased, Long Acting Opioids Increased

Wednesday, September 28, 2016 PR Newswire

ST PAUL Minn Sept 28 2016 PRNewswire Prime Therapeutics LLC Prime a pharmacy benefit manager serving over 22 million members nationally analyzed pharmacy claims for both short and longacting opioids including an evaluation of long acting opioids with and without abusedeterrent properties The rese..

Wyss Institute launches ReadCoor to commercialize 3D in situ gene sequencing technology

Wednesday, September 28, 2016 PR Newswire

BOSTON Sept 28 2016 PRNewswireUSNewswire The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced that its FISSEQ fluorescent in situ sequencing technology will be commercialized by a newly formed company ReadCoor Inc FISSEQ is a spatial gene sequencing tec..

Brooks Life Science Systems and Interactive Software Announce Technology Partnership

Wednesday, September 28, 2016 PR Newswire

CHELMSFORD Mass Sept 28 2016 PRNewswire Brooks Life Science Systems Brooks and Interactive Software Ltd today announced a partnership that will bring patient and donor sample informed consent and clinical data management capabilities to Brooks existing ISIDOR sample management informatics platform..

Eleventa Announce Completion of Patient Enrollment in Phase 3 Clinical Trial of CRTH2 Antagonist Timapiprant for the Treatment of Allergic Asthma

Wednesday, September 28, 2016 PR Newswire

MOSCOW September 28 2016 PRNewswire Eleventa Ltd Moscow Russia a portfolio company of Maxwell Biotech Venture Fund MBVF and its development partner Oxagen Limited Abingdon UK today announced the completion of patient enrollment in the a Phase 3 clinical study of Timapiprant formerly OC000459 for..

Foamix Pharmaceuticals Ltd. Announces Pricing of its $57 Million Follow-on Offering of Ordinary Shares

Wednesday, September 28, 2016 PR Newswire

REHOVOT Israel and BRIDGEWATER New Jersey Sept 28 2016 PRNewswire Foamix Pharmaceuticals Ltd Foamix Nasdaq FOMX a clinical stage specialty pharmaceutical company focused on developing and commercializing its proprietary topical foams to address unmet needs in dermatology today announced the prici..

Shineco, Inc. Completes Initial Public Offering and Commences Trading on NASDAQ Capital Market

Wednesday, September 28, 2016 PR Newswire

BEIJING China Sept 28 2016 PRNewswire Shineco Inc Shineco or the Company a producer and distributor of Chinese herbal medicines organic agricultural produce specialized textiles and other health and wellbeing focused plantbased products in China today announced that it completed the initial public..

Working Mother Magazine Names Astellas Among 100 Best Companies in the US Across All Industries

Wednesday, September 28, 2016 PR Newswire

NORTHBROOK Ill Sept 28 2016 PRNewswire Astellas was named one of Working Mother Magazines 100 Best Companies in the US for its commitment to establishing a corporate culture supportive of working moms and their families The 100 Best Companies is featured in the OctoberNovember issue of Worki..

Seattle Back Specialist Named as Area \"Top Doc\"

Wednesday, September 28, 2016 PR Newswire

BOTHELL Wash Sept 28 2016 PRNewswire Spine Institute Northwest founder Dr Solomon Kamson MD PhD recently was named one of the Seattle areas Top Docs and is featured in Seattle Metropolitan magazine The publications 11th annual Best of the City edition honors 911 doctors physician assistants and nu..

Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients

Wednesday, September 28, 2016 PR Newswire

ABBOTT PARK Ill Sept 28 2016 PRNewswire Abbott NYSE ABTtoday announced that the US Food and Drug Administration FDA has approved the companys FreeStyle Libre Pro system a revolutionary continuous glucose monitoring CGM system for healthcare professionals to use with their patients with diabetes ..

EIP Pharma announces issuance of multiple new patents covering VX-745, a selective p38 MAP kinase alpha inhibitor for Alzheimer\'s disease and ischemic stroke recovery

Wednesday, September 28, 2016 PR Newswire

CAMBRIDGE Mass Sept 28 2016 PRNewswire EIP Pharma LLC wwweippharmacom today announced that the US Patent Office issued on August 30 2016 the following two patents US Patent No 9427438 entitled Compositions and methods for treating Alzheimers disease The 438 patent claims administration of VX74..

Boehringer Ingelheim boosts immune-oncology pipeline through collaboration with ViraTherapeutics

Wednesday, September 28, 2016 PR Newswire

RIDGEFIELD Conn Sept 28 2016 PRNewswire Boehringer Ingelheim and ViraTherapeutics today announced a longterm collaboration to jointly develop a next generation oncolytic virus therapy platform and to investigate ViraTherapeutics lead candidate VSVGP Vesicular Stomatitis Virus VSV glycoprotein GP a..

Bayer to Showcase Latest Oncology Research at ESMO 2016 Congress

Wednesday, September 28, 2016 PR Newswire

WHIPPANY NJ Sept28 2016 PRNewswire Bayer announced today that the latest research across its growing oncology portfolio will be presented at the European Society of Medical Oncology ESMO 2016 Congress taking place on October 711 in Copenhagen Denmark The data span a variety of difficulttotreat can..

Medicines360 and Population Services International Announce New Partnership to Expand Access to Hormonal IUDs to Women in Africa

Wednesday, September 28, 2016 PR Newswire

SAN FRANCISCOand WASHINGTON Sept 28 2016 PRNewswire Medicines360 a global nonprofit pharmaceutical company and Population Services International PSI a leading global health organization working in reproductive health announced today an agreement to expand access to Medicines360s hormonal intrauter..

Neurim Pharmaceuticals Announces First Patients\' Enrollments in ReCOGNITION - Phase II Clinical Trial of Piromelatine for Mild Alzheimer\'s Disease

Wednesday, September 28, 2016 PR Newswire

TEL AVIV Israel September 28 2016 PRNewswire Neurim Pharmaceuticals Neurim announced today that the first patients have been enrolled in the ReCOGNITION study of its novel drug piromelatine for Alzheimers disease AD ReCOGNITION is a Phase 2 randomized placebo controlled dose ranging study of Pi..

Novan Announces Both SB204 Phase 3 Pivotal Trials Fully Enrolled

Wednesday, September 28, 2016 PR Newswire

DURHAM NC Sept 28 2016 PRNewswire Novan Inc the Company or Novan NASDAQ NOVN today announced that the last patient has been randomized in the Companys two identically designed Phase 3 pivotal clinical trials to evaluate the efficacy and safety of topical nitric oxidereleasing product candidate SB..

Dr. Daniel Alkon Appointed President of Neurotrope, Inc.

Wednesday, September 28, 2016 PR Newswire

NEW YORK Sept 28 2016 PRNewswire Neurotrope Inc OTCQBNTRP a company focused on developing drugs to treat neurodegenerative diseases including Alzheimers disease today announced that it has appointed its Chief Scientific Officer Dr Daniel Alkon to the additional role of President After approximat..

Relmada Therapeutics\' Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston

Wednesday, September 28, 2016 PR Newswire

NEW YORK Sept 28 2016 PRNewswire Relmada Therapeutics Inc OTCQB RLMD a clinicalstage company developing novel therapies for the treatment of central nervous system CNS diseases today announced that Dr Richard Mangano the companys chief scientific officer will participate in a panel of thought lead..

Emerald Medical Applications Enters Joint Sponsorship Agreement with the Hispanic Professionals Association Inc. NY

Wednesday, September 28, 2016 PR Newswire

PETACH TIKVA Israel September 28 2016 PRNewswire Emerald Medical Applications Corp OTCQB MRLA Emerald or the Company the Israelibased company engaged in the development and sale of DermaCompare its proprietary artificial intelligence technology for the early diagnosis of melanoma and other skin ..

Principal Researchers Honored at Annual Meeting of the Oligonucleotide Therapeutics Society

Wednesday, September 28, 2016 PR Newswire

MONTREAL Sept 28 2016 PRNewswire The Oligonucleotide Therapeutics Society OTS has announced its 2016 Award Series as part of its 2016 Annual Meeting held September 2528 2016 in Montral Quebec CanadaThis year the OTS is recognizing four outstanding scientists for their contributions to the field of..

Bracket Announces Release of \"Intelligently Designed\" eCOA Solution for the Vineland Adaptive Behavior Scale

Wednesday, September 28, 2016 PR Newswire

WAYNE Pa Sept 28 2016 PRNewswire Bracket a leading clinical trial technology and specialty services provider today released a sophisticated electronic clinical outcomes assessment eCOA solution for Pearsons Vineland Adaptive Behavior Scale Second Edition VinelandII an assessment tool used to ident..

TOP